Aerotab Non-aspirin Tablet
Product Images NDC 55305-126

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Aerotab Non-aspirin (NDC 55305-126). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aero Healthcare, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

250 (V1.atna250.bx Ol)

250 (V1.atna250.bx Ol)
This is a drug facts sheet that provides information on a pain reliever and fever reducer medication. The active ingredient in each tablet is 500mg acetaminophen, which helps with minor aches and pains, headaches, muscular aches, toothaches, menstrual cramps, and fever reduction. The sheet includes warnings about severe liver damage and skin reactions. It also contains dosage instructions and other information such as inactive ingredients, overdose warnings, and storage instructions. The medication comes in a packet of two tablets, and the manufacturer is Aero Healthcare, located in Valley Cottage, NY, USA.*
FDA Label Image

50 (V1.atna50us.bx Ol)

50 (V1.atna50us.bx Ol)
This is a drug facts sheet for a non-aspirin pain reliever and fever reducer medication containing 500mg of acetaminophen per tablet. It is to be taken every 4 to 6 hours, with a maximum of 8 tablets in a 24-hour period. The medication is intended to temporarily relieve minor aches and pains associated with headaches, muscular aches, backaches, minor pains, or arthritis, the common cold, toothaches, menstrual cramps, and fever reduction. The product's packaging program is manufactured by a healthcare company, Aero Healthcare in the USA. The warning is provided to prevent severe liver damage that may occur if an adult takes more than 4,000mg of acetaminophen 24 hours with other drugs containing acetaminophen or if an adult has 3 or more alcoholic drinks every day while using the product. Symptoms of a skin reaction may include skin reddening, blisters, or a rash. Inactive ingredients include corn starch, povidone, pregelatinized starch, sodium starch glycolate, and stearic acid.*
FDA Label Image

Pouch (V2.atna001 Outline)

Pouch (V2.atna001 Outline)
This is a medication containing Acetaminophen, which is used as a pain reliever and fever reducer. There are 2 tablets per packet with tamper-evident packaging. It is used for temporary relief of minor aches and pains associated with headaches, common cold, and menstrual cramps, or to reduce fever. Overdose can result in severe liver damage. It is essential to ask a doctor before use if you have a fever or liver disease. For adults, it is recommendable to take 2 tablets every 4-6 hours, consuming no more than 8 tablets in any 24 hour period. The product packaging also provides additional usage instructions and product information.*
FDA Label Image

100 (V2.atna100us Bx Outline (1))

100 (V2.atna100us Bx Outline (1))
This text describes the drug facts of a medication containing acetaminophen 500mg, which is used to temporarily relieve minor aches and pains against multiple causes such as muscular pain, headache, toothache, menstrual cramps, fever, etc. However, the product can cause severe liver damage if more than 4,000mg of acetaminophen is consumed within 24 hours, so it is suggested to avoid it if allergic to acetaminophen or with other products that contain it. The packet contains two tablets with the advised dosage being 2 tablets every 4 to 6 hours but not more than 8 tablets in 24 hours. Children under 12 years of age should not use this product. Reading all the warnings and directions before use is advised, and the product contains inactive ingredients like corn starch, povidone, and sodium starch glycolate.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.